Angel Pharma gets Chinese approval to initiate phase 1/1b trial of mupadolimab
28 Sep 2022 //
PHARMABIZ
Align Technology Shares Findings From New Clinical Study That Validates
27 Oct 2021 //
GLOBENEWSWIRE
28 Sep 2022 //
PHARMABIZ
27 Oct 2021 //
GLOBENEWSWIRE